EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?

Delphine Gastineau iD, Claire Goumard, Alexandre Doussot, Marc-Antoine Allard iD, Raphael Venezia, Serena Langella, Guillaume Millet iD, Ruth Bustamante, Christian Hobeika, Rami Rhaiem, Stylianos Tzedakis, Heithem Jeddou iD und 27 weitere

World Journal of Surgery · 2026

DOI: 10.1002/wjs.70491 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Surgery, 2026. Verfasst von Delphine Gastineau und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, AP-HP, Hôpitaux Universitaires Henri Mondor, Créteil, France. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Benchmarking, Hepatectomy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy with rising incidence and poor prognosis. Surgical resection remains the only curative option, with outcomes driven by R0 margins and lymphadenectomy (LND). While open liver resection (OLR) is standard, laparoscopic (LLR) and robotic liver resection (RLR) are increasingly used, with concerns about their oncologic adequacy.

Objective

To assess the association between composite surgical benchmark attainment (R0 + LND) and short‐ and long‐term outcomes after ICC resection, stratified per surgical approach.

Methods

A retrospective multicenter analysis was conducted including 240 patients treated from 2010 to 2024. The primary endpoint was achievement of both R0 resection and LND. Secondary endpoints included 90‐day mortality, overall (OS), and disease‐free survival (DFS).

Results

Among the 240 included patients 38.8% met surgical benchmarks (R0 + LND), with rates varying by approach: OLR 51.1%, RLR 44.4%, and LLR 14.5% ( p < 0.001). 90‐day mortality was 5.0% (12/240) overall, with no significant difference between surgical approaches ( p = 0.219). One and 3‐year overall survival was 79%/30% for OLR, 95%/89% for LLR, and 90%/81% for RLR ( p < 0.001). Multivariable analysis identified tumor multiplicity as an independent predictor of mortality (HR = 2.18, p = 0.003), while LLR was independently protective (HR = 0.15, p < 0.001); RLR showed a non‐significant protective trend.

Conclusion

Although OLR and RLR more frequently met oncological benchmark criteria, only LLR was independently associated with improved overall survival, highlighting a potential disconnect between benchmark adherence and long‐term outcomes in ICC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsBenchmarkingHepatectomyLaparoscopyRobotic Surgical ProceduresHumansFemaleRetrospective StudiesMaleLymph Node ExcisionMiddle AgedAgedTreatment OutcomeDisease-Free SurvivalMargins of Excision

Stichwörter der Autor:innen

intra‐hepatic cholangiocarcinomaliver surgerylong‐term outcomeslymphadenectomynode dissection

Autor:innen und Institutionen

  • Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, AP-HP, Hôpitaux Universitaires Henri Mondor, Créteil, France.
  • Faculté de Santé, GRCT OPTIMA, Univ Paris Est Créteil, Créteil, France.
  • Department of Hepatobiliary and Liver Transplantation Surgery, AP-HP, Hôpital Pitié Salpêtrière, CRSA, Sorbonne Université, Paris, France.
  • Department of Digestive and Surgical Oncology, Liver Transplantation Unit, CHU Besancon, Besançon, France.
  • Hôpital Paul Brousse, Centre Hépato-Biliaire, AP-HP, Villejuif, France.
  • Inserm, Université Paris-Saclay, UMRS 1193, FHU Hepatinov, Villejuif, France.

ORCID-Profile: Delphine Gastineau, Marc-Antoine Allard, Guillaume Millet, Heithem Jeddou, David Fuks, Raffaele Brustia

Zitieren

APA

Gastineau, D., Goumard, C., Doussot, A., Allard, M. A., Venezia, R., Langella, S., Millet, G., Bustamante, R., Hobeika, C., Rhaiem, R., Tzedakis, S., Jeddou, H., Le Floch, B., Valverde, A., Peru, N., Pessaux, P., Giannone, F., Mabrut, J. Y., Mohkam, K., …, & AFC‐ICC‐2009, AFC‐LLR‐2018, PRS‐2019 and FRIES‐ACHBPT‐2024 Study group (2026). Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?. World Journal of Surgery. https://doi.org/10.1002/wjs.70491

Vancouver

Gastineau D, Goumard C, Doussot A, Allard MA, Venezia R, Langella S, et al. Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?. World Journal of Surgery. 2026. doi:10.1002/wjs.70491

BibTeX
@article{Gastineau2026,
  author = {Gastineau, Delphine and Goumard, Claire and Doussot, Alexandre and Allard, Marc-Antoine and Venezia, Raphael and Langella, Serena and Millet, Guillaume and Bustamante, Ruth and Hobeika, Christian and Rhaiem, Rami and Tzedakis, Stylianos and Jeddou, Heithem and Le Floch, Bastien and Valverde, Alain and Peru, Nicolas and Pessaux, Patrick and Giannone, Fabio and Mabrut, Jean Yves and Mohkam, Kayvan and Sa Cunha, Antonio and Salloum, Chady and Blanc, Pierre Yves and Le Roy, Bertrand and Kawai, Takayuki and Farges, Olivier and Hofmeyr, Stefan and Fuks, David and Truant, Stéphanie and Cherqui, Daniel and Ferrero, Alessandro and Boleslawski, Emmanuel and Regimbeau, Jean-Marc and Vibert, Eric and Sommacale, Daniele and Soubrane, Olivier and Scatton, Olivier and Laurent, Alexis and Brustia, Raffaele and AFC‐ICC‐2009, AFC‐LLR‐2018, PRS‐2019 and FRIES‐ACHBPT‐2024 Study group, AFC‐ICC‐2009, AFC‐LLR‐2018, PRS‐2019 and FRIES‐ACHBPT‐2024 Study group},
  title = {Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?},
  journal = {World Journal of Surgery},
  year = {2026},
  doi = {10.1002/wjs.70491}
}
Kostenlos starten →